Lab
Aristotle Diagnostic Laboratories, LLC
Aristotle Diagnostic Laboratories, LLC was paid $363K by Medicaid between Mar 2023 and Dec 2024, across 24 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 11% of everything it billed.
33Billing provider infoARISTOTLE DIAGNOSTIC LABORATORIES, LLC
CONWAY, AR 72034
CONWAY, AR 72034
33aNPI1023751633assigned 04/20/2022
33bProvider typeClinical Medical Laboratory
28Total paid$363K
24GClaims12,368
24DCodes billed24
24AFirst – last monthMar 2023 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Arkansas
Rank by total paid#10 of 24
Median peer was paid$53K
This provider vs. median6.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 2,316 | $77K | |
| 2024incomplete | 10,052 | $287K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 11% | 1,598 | 1,205 | $41K |
| 87631 | 9.0% | 522 | 433 | $33K | |
| 87640 | 8.1% | 1,132 | 975 | $29K | |
| 87641 | 7.5% | 1,078 | 894 | $27K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 7.4% | 1,098 | 915 | $27K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 6.2% | 319 | 285 | $23K |
| 87634 | 5.9% | 418 | 357 | $21K | |
| 87481 | 4.8% | 721 | 609 | $18K | |
| 87581 | 4.7% | 575 | 473 | $17K | |
| 87541 | 4.4% | 523 | 434 | $16K | |
| 87498 | 4.4% | 524 | 435 | $16K | |
| 87653 | 3.6% | 566 | 502 | $13K |
12 more codes
| 87529 | 3.3% | 405 | $12K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3.1% | 403 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.1% | 405 | $11K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.0% | 402 | $11K |
| 87500 | 2.7% | 445 | $10K | |
| 87563 | 2.7% | 565 | $10K | |
| 87511 | 2.6% | 402 | $9K | |
| 87486 | <1% | 114 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 36 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 68 | $2K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 18 | $570.52 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRICE, MATTHEW (MANAGING PARTNER)